Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Janssen (OTC Products)

M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A portfolio of over-the-counter products. The portfolio comprises products that are based on the anti-fungal substances econazole and ketoconazole and are used to treat common fungal infections of the skin.

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • Hochstrasse 201
  • 8200 Schaffhausen
  • Switzerland

Janssen (OTC Products) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Janssen (OTC Products)‘s full profile, request access.

Request full access to PitchBook

Janssen (OTC Products) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Janssen (OTC Products)‘s full profile, request access.

Request full access to PitchBook